The current price of BEAM is $25.14 — it has decreased by 9.54% since the previous close. Data as of Nov 5, 2026.
BEAM is down 11.71% over the past week, down 2.77% over the past month and up 8.19% over the past year. The price is below its 200-day moving average of $28.07.
Analysts' average 12-month price target for BEAM is $66.00, which implies 162.53% upside from the current price. Individual estimates range from $39.00 to $80.00.
Of the 15 analysts covering Beam Therapeutics Inc., 1 rates it a strong buy, 12 rate it a buy and 2 rate it a hold. The overall consensus is bullish. Analyst ratings are opinions and do not guarantee future performance.
Beam Therapeutics Inc. has a market capitalization of $2.6B. The company belongs to the Healthcare sector. Compare it with other companies in the stock screener.
In the latest trading session BEAM moved between $25.01 and $27.48, a range of 9.82% of its current price.
Over the past 52 weeks BEAM has traded between $20.23 and $38.26. The current price is 34.29% below its 52-week high.
Figures as of Nov 5, 2026. This information is provided for general purposes only and is not investment advice.